Back to search

Article

Validation of a simplified HPV genotyping assay designed for cervical screening in low-resource settings

2024-10-22

Abstract excerpt

<h4>Introduction</h4> Human papillomavirus (HPV) genotype predicts cervical cancer risk, and genotyping could help guide management of HPV positives as part of cervical screening. An isothermal amplification HPV extended genotyping test (ScreenFire HPV RS assay) can assay up to 96 controls/samples in one hour plus preparation time. A novel format with pre-aliquoted reagents and an anti-contamination component (Zeb...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
23786a7d-c0e7-5d63-924b-ed3d27f0c15f
DOI
10.1101/2024.10.21.24315750
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Validation of a simplified HPV genotyping assay designed for cervical screening in low-resource settingsDOI 10.1101/2024.10.21.24315750
Validation of a simplified HPV genotyping assay designed for cervical screening in low-resource settings.Semantic proximity
Redesign of a rapid, low-cost HPV typing assay to support risk-based cervical screening and management.Semantic proximity
A rapid HPV typing assay to support global cervical cancer screening and risk-based management: A cross-sectional study.Semantic proximity
Extended HPV typing as an efficient alternative within HPV-based screening programs.Semantic proximity
Assessment of Accuracy and Reliability: Validation trial for a Fluorescent Probe-Based Real-Time PCR Assay Kit in Detecting Human Papillomavirus Nucleic AcidSemantic proximity
Isothermal Technologies for HPV Detection: Current Trends and Future PerspectivesSemantic proximity
Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the International Guidelines for Human Papillomavirus Test Requirements for Cervical ScreeningSemantic proximity
The Valgent4 protocol: Robust analytical and clinical validation of 11 HPV assays with genotyping on cervical samples collected in SurePath mediumSemantic proximity
Urinary high-risk HPV DNA detection to enhance cervical cancer screening in developing countriesSemantic proximity
Comparison of the AmpFire® Multiplex HPV Assay to the Xpert® HPV Assay for detection of human papillomavirus and cervical disease in women with human immunodeficiency virus: A pragmatic performance evaluationSemantic proximity
An integrated isothermal nucleic acid amplification test to detect HPV16 and HPV18 DNA in resource-limited settingsSemantic proximity
A Comparison of the Roche Cobas HPV Test With the Hybrid Capture 2 Test for the Detection of High-Risk Human Papillomavirus Genotypes.Semantic proximity
Select a neighboring publication to make it the new centre.